Neurology

The FDA is permitting marketing of a replaceable urinary prosthesis for female adults with impaired detrusor contractility.

Neuroprotective nutrients appear to enhance cognition, memory, and other impaired functions seen in patients with Alzheimer's disease.

In response to the recent article by Gary M. Franklin, MD, MPH, titled "Opioids for chronic non-cancer pain: A position paper of the American Academy of Neurology," we wish to address a number of issues.

Sleep disorders may require independent diagnosis and management, researchers say.

A metaanalysis shows that levels of an antioxidative endogenous metabolic byproduct-uric acid-are correlated with disease activity in multiple sclerosis.

Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.

The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.

Clinical pharmacists can reduce anti-epileptic drug (AED) prescription errors that commonly result from incomplete or poor documentation.

Disease modifying therapy maintains effects of interferon in the body for a longer duration.

In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.

Postmenopausal women who consume adequate amounts of potassium have reduced stroke risk.

For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.

Genzyme's alemtuzumab (Lemtrada) and Biogen's dimethyl fumarate (Tecfidera) showed sustained efficacy in a broad range of MS patients.

For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.

Increased salt intake may magnify the risk of relapses in patients with multiple sclerosis.

Scientists discover how to stop cells from attacking healthy tissue.

Multiple sclerosis patients who used a balance board accessory for a video game console saw changes in brain connections and improved their balance.

Phase I study deems treatment safe and tolerable in humans.

Phase I study deems treatment safe and tolerable in humans.

Specialty therapies for rheumatoid arthritis, multiple sclerosis, and breast cancer tended to have positive functional and clinical outcomes for patients.

Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.

The viral Ice Bucket Challenge and the first effort to estimate the prevalence of amyotrophic lateral sclerosis have raised awareness of the neurodegenerative disease.

We should not be ashamed to talk openly about something that is nothing more than a neurotransmitter imbalance.

Many patients with Parkinson's disease do not receive treatment for their depressive symptoms.